Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.

N K Cheung(Memorial Sloan Kettering Cancer Center), Irene Y. Cheung, Glenn Heller(Memorial Sloan Kettering Cancer Center), Hong-Fen Guo(Memorial Sloan Kettering Cancer Center)

PubMed

July 1, 2000

Cited by 79

Related Papers

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

|Journal of Clinical Oncology|1987|417

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid

|Blood|1994|303

Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura

|Blood|1983|299

The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer

|Clinical Cancer Research|2020|281

Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.

|PubMed|1990|156